Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06088277 · ClinicalTrials.gov registry record · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
A NA study of HIV Infections, sponsored by Boston University.
- Recruiting
- Registry status
- NA
- Development phase
- 266
- Enrollment target
- 2
- Study locations
NCT06088277: Recruiting NA study of HIV Infections, sponsored by Boston University.
NCT06088277 is a NA study of HIV Infections that is actively recruiting participants, run by Boston University. The registered enrollment target is 266 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06088277, a NA study of HIV Infections, is actively recruiting participants, sponsored by Boston University.
- RECRUITING
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all study procedures. For both the pilot and the randomized clinical trial (RCT), recruitment will be conducted at 4 Community Health Center dental clinics (Codman Square, East Boston (both East Boston and South End locations), Geiger Gibson, and Upham's Community Health Centers). Recruitment materials (flyers and permission to contact forms) may also be made available at other clinics within the health centers. The study will enroll English and Spanish-speaking patients who have at least one risk factor for HIV but are HIV-negative. Patients enrolled in the pilot will complete self-report surveys at baseline, 1 and 2 months. Participants enrolled in the RCT will complete self-report surveys baseline, 3, 6, and 12 months after baseline; receive and respond to TM assessments during the 6-month intervention.
Primary Outcome
The total number of participants that obtain HIV testing will be assessed from answers to a question in a study questionnaire.
Conditions Studied
Interventions
- BEHAVIORAL TM HIV
- BEHAVIORAL TM HL
Study Locations (2)
Massachusetts
- South End Community Health Center - Boston
- East Boston Neighborhood Health Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2024-08-16 |
| Est. Completion | 2027-04-14 |
| Phase | NA |
What NCT06088277 shows while recruiting
NCT06088277 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (40% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which TM HIV is the first listed.
NCT06088277 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06088277 about?
NCT06088277 is a clinical study titled "Texting to Reduce Human Immunodeficiency Virus (HIV) Risk". This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participant...
What is the current status of trial NCT06088277?
This trial is currently recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2024-08-16. Estimated completion is 2027-04-14.
What conditions does trial NCT06088277 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT06088277?
The interventions under investigation include: TM HIV (BEHAVIORAL), TM HL (BEHAVIORAL).
Who is sponsoring clinical trial NCT06088277?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06088277 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06088277's enrollment target sits among peer trials
266 135th of 542 higher than 408 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
- NCT06560866 · 266 participants · NA
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI